Skip to main content
. 2013 Dec 9;2013(12):CD008846. doi: 10.1002/14651858.CD008846.pub2

De Zulueta 1961 UGA.

Methods Dates of study: 1959‐1960
Location of study: Uganda
Malaria endemicity (prevalence): 34% in children 2‐9 years; 17% in all ages [Moderate]
Transmission season: Rainy season April to May, August to November
Malaria species: P. falciparum, P. malariae
Vector species: A. gambiae, A. funestus
Study design: Uncontrolled before‐and‐after study
Evaluation design: Cross‐sectional surveys
Participants Age groups included: All ages
Sample size
Intervention group 1 mean (range): 30,384 (10,303 ‐ 59,605)
Interventions Intervention group 1 (North Kigezi): MDA administered to all persons with chloroquine 600 mg and pyrimethamine 50 mg every three months for four rounds at the time of IRS application from May 1959 to May 1960. Coverage 80%. Co‐intervention with IRS.
Outcomes Parasitaemia prevalence
Gametocytaemia prevalence
No adverse event surveillance conducted
No adverse events reported
Notes Outcomes assessed in a sub‐sample of the treated population.
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) High risk No comparison group
Allocation concealment (selection bias) High risk No comparison group
Baseline imbalance (selection bias) High risk No comparison group
Contamination protection High risk No comparison group
Blinding of participants and personnel (performance bias) 
 All outcomes High risk No comparison group
Blinding of outcome assessment (detection bias) 
 All outcomes High risk No comparison group
Incomplete outcome data (attrition bias) 
 All outcomes Low risk Cooperation of the local inhabitants was remarkably good and not a single dwelling was left unsprayed
Selective reporting (reporting bias) Low risk Increased number of samples from hyperendemic areas in the post‐intervention survey
Other bias Low risk No other bias detected